Congress
3rd Symposium on Parathyroid Fluorescence – On 25th to 26th – Geneva (Switzerland)
0
Congress
As every year, the surgical association of endocrinology, CAEK, gathered to exchange on various themes of the endocrinology, the scientific discoveries in molecular biology and the cooperation between different medical specialization. This 38th congress will study the current results of endocrine surgery theses and also on the clinical and scientific questions of the patient prognosis and his quality of life for thyroid surgery, the parathyroid glands, adrenal and pancreatic.
For this congress we shall be delighted to meet you on our booth to present to you our new device, the FLUOBEAM® LX. Be the first to discover our latest innovation dedicated to the thyroid and parathyroid glands surgery.
Congress
Main association of endocrine surgery in North America, the American Association of Endocrine Surgeons organizes his 40th congress in Los Angeles. We would be pleased to exchange with you about on the available applications of our new device, the FLUOBEAM® LX. This device is the only one on the market to propose an application allowing to visualize parathyroid glands by autofluorecence and their perfusion. Our team wait for you on our booth to exchange with you in more detail.
Congress
The ACS Clinical Congress features outstanding education and training opportunities at the premier annual surgical meeting for surgeons, surgery residents, medical students, and members of surgical teams.. We would be pleased to exchange with you about on the available applications of our new device, the FLUOBEAM® LX. This device is the only one on the market to propose an application allowing to visualize parathyroid glands by autofluorecence and their perfusion. Our application engineers wait for you on our booth to exchange with you in more detail.
Congress
This year the AFIB’s days will take place in Re (France). For these 3 days you will have the opportunity to exchange on various subjects such as robotics, artificial intelligence.
Fluoptics is proud to assist it and to present to you our lastest innovation the FLUOBEAM® LX. Be the first to come to test it.
Congress
We are proud to present to you during this World Congres of Thyroid Cancer the FLUOBEAM®, which is able to identify parathyroid glands by autofluorescence but also their perfusion, real bonus and gain in the prevention of the post-operative complications. Come to discover or to rediscover with our application engineers the various applications of the FLUOBEAM® on the booth 12.
Congress
FLUOPTICS© is a French company which develops innovative solutions of imaging by fluorescence to guide in real time the surgeon during the operative act.This year FLUOPTICS© will be present to propose you our new device,the FLUOBEAM® LX system, which is dedicated to thyroid and parathyroid surgery. This device is the only one on the market to propose an application allowing to visualize parathyroid glands by autofluorecence and their perfusion. Our application engineers wait for you on our booth to exchange with you in more detail.
Congress
Thyroid and parathyroid surgery are two common surgical procedures that have become very safe thanks to the surgical advances. However, hypoparathyroidism remains the current concern of thyroid surgery.
New fluorescence imagining techniques, have been developed to help the detection of parathyroid glands and confirm their vascularization. This has opened a new exciting area of research for surgeons and scientists.
Moreover, our fluorescence imagining system FLUOEAM® has received the market authorization from FDA to help in real-time localization of parathyroid tissue during procedures such as thyroidectomy or parathyroidectomy.
In this context, we are delighted to see you at this first international symposium and to present to you our fluorescence imaging solutions and their various applications.
We also invite you to our symposium presented by Mrs. Odile ALLARD the CEO of Fluoptics© and Mr. Philippe RIZO the CTO of Fluoptics©, which is based on the latest Fluoptics© innovations. This symposium will take place on February 28th from 6 to 7 pm.
Press & Media
Last November FLUOPTICS receives the market authorization from FDA for FLUOBEAM® to detect parathyroid tissue in real time during surgery.
It is a recognition of the performance of the FLUOBEAM® and for the development of fluorescence imaging.
Today, we are highlighted in the Presences revue of the Grenoble CCI for this market authorization.
For more information, please click on the link Présences_CCI de Grenoble.
Press & Media
FLUOPTICS receives the market authorization from FDA for FLUOBEAM® to detect parathyroid tissue in real time during surgery. The FLUOBEAM® Imaging System becomes the first and unique system certified for this indication.
The FLUOBEAM® provides, earlier, real-time location of parathyroid tissue during surgical procedures such as thyroidectomy (surgery to remove all or part of the thyroid) and parathyroidectomy (surgery to remove one or more parathyroid glands). The early detection of theses glands allows reduces postoperative hypocalcemia.
It is a recognition of the performance of the FLUOBEAM® and for the development of fluorescence imaging.
Congress
As every year, the surgical association of endocrinology, CAEK, gathered to exchange on various themes of the endocrinology, the scientific discoveries in molecular biology and the cooperation between different medical specialization. This 37th congress will study the current results of endocrine surgery theses and also on the clinical and scientific questions of the patient prognosis and his quality of life for thyroid surgery, the parathyroid glands, adrenal and pancreatic.
For this congress we shall be delighted to meet you on our booth to present to you our FLUOBEAM® that you could test. Be the first to discover our latest application dedicated to the thyroid and parathyroid glands surgery.
Publications
Indocyanine green fluorescence (ICGF) and parathyroid autofluorescence (AF) are two new techniques that aid in the identification of parathyroid glands (PG) intraoperatively during thyroidectomy. There is no study comparing the efficacy of these techniques.
Publications
Intraoperative localisation and preservation of parathyroid glands improves outcomes following thyroid and parathyroid surgery. This can be facilitated by fluorescent imaging and methylene blue; a fluorophore is thought to be taken up avidly by parathyroid glands.
Publications
Parathyroid gland (PG) identification during thyroid and parathyroid surgery is challenging. Accidental parathyroidectomy increases the rate of postoperative hypocalcaemia. Recently, autofluorescence with near infrared light (NIRL) has been described for PG visualization. The aim of this study is to analyze the increased rate of visualization of PGs with the use of NIRL compared to white light (WL).
Publications
Parathyroid glands (PGs) can be particularly hard to distinguish from surrounding tissue and thus can be damaged or removed during thyroidectomy. Postoperative hypoparathyroidism is the most common complication after thyroidectomy. Very recently, it has been found that the parathyroid tissue shows near-infrared (NIR) auto-fluorescence which could be used for intraoperative detection, without any use of contrast agents.
Publications
Identification of parathyroid glands may be challenging during thyroid and parathyroid surgery. Accidental resection of the glands may increase the morbidity of the surgery. The aim of this study was to evaluate accuracy in identification of autofluorescent parathyroid glands with the use of near infrared light in real time.